Search Results for: stem cell biotech

GMO Sapiens book teaser: time to talk frankly on human genetic modification

GMO-Sapiens-Book-Cover

I’ve written a new book on human genetic modification. This is my second book as the first one was Stem Cells: An Insider’s Guide, which is currently the top stem cell book on Amazon. The new book is called GMO Sapiens: The Life-Changing Science of Designer Babies.  You can pre-order it here at Amazon or over here at my publisher’s …

GMO Sapiens book teaser: time to talk frankly on human genetic modification Read More »

Why interview Steven Pinker on my blog if I strongly disagree with him?

blog-ethos

Earlier this week I posted an interview with Steven Pinker on CRISPR, human germline modification, and bioethics. With only a few exceptions, I strongly disagree with Pinker’s philosophy in these areas and I knew going into the interview that his answers would likely go against my own views. I also expected the interview would anger …

Why interview Steven Pinker on my blog if I strongly disagree with him? Read More »

Steven Pinker interview: case against bioethocrats & CRISPR germline ban

Steven-Pinker

CRISPR-Cas9 gene editing technology is red-hot right now and I’ve been doing interviews with various thought leaders on it, which today includes Steven Pinker. This technology has great power for research in the lab and there are hypothetical transformative clinical applications of CRISPR too. The latter efforts could include experimental attempts at reversal of disease-causing …

Steven Pinker interview: case against bioethocrats & CRISPR germline ban Read More »

Global transhumanism leader Natasha Vita-More on human germline modification

Transhuman-Visions-2-14

In my continuing series of conversations with thought leaders related to heritable human modification, today’s post is an interview with Natasha Vita-More, a pioneer in the transhumanism movement and Chairman of the Board of Directors of Humanity+ (H+), the global transhumanist organization. Where do you see transhumanism today? Has it changed over the years? What …

Global transhumanism leader Natasha Vita-More on human germline modification Read More »

Guest Post by Chris Scott–The Great CRISPR Controversy: What’s Next?

CRISPR-primates

A decade ago I wrote an article in the journal Nature Biotechnology about the rise of a new gene editing technology called zinc finger nucleases (ZNF). It was one of those “drumbeat” discoveries: at the time, my sense was it would revolutionize how we deliver genes to cells and tissues, and profoundly change the way …

Guest Post by Chris Scott–The Great CRISPR Controversy: What’s Next? Read More »

Was Fujifilm CDI acquisition a good move by the companies?

Fujifilm-Logo

The big stem cell news already this week is the acquisition by Fujifilm of Cellular Dynamics International (CDI) for a whopping $307 million dollars or about $16.50 per CDI share. You can read the press release here. Update: The entity is now known as Fujifilm Cellular Dynamics. It was less than two years ago that CDI did …

Was Fujifilm CDI acquisition a good move by the companies? Read More »

ARM Asks FDA for Clarification on Draft Guidance on Minimal Manipulation

Alliance-for-Regenerative-Medicine

In the last few months the FDA has taken steps toward crystalizing regulatory oversight of stem cell and more broadly cell and tissue-based therapies. These steps come in the form of several draft guidances  (see here, here, and here) . The Alliance for Regenerative Medicine (ARM) has responded to the draft guidance on Minimal Manipulation. For example, ARM has …

ARM Asks FDA for Clarification on Draft Guidance on Minimal Manipulation Read More »

ViaCyte CEO Laikind Interview: Trial Update, Melton, & Future

VC-01-post-implant-final1-e1503703572933, viacyte

It’s been exciting to watch the recent developments in using stem cells as the basis for treatments for Type I Diabetes. One of the major players in this arena is the privately-held company, ViaCyte. In this post, I interview ViaCyte President and CEO, Paul Laikind. The topics include their VC-01 product, the Encaptra device, an update on …

ViaCyte CEO Laikind Interview: Trial Update, Melton, & Future Read More »